Evidence map›Paper›PMID 40206535›Full record

ArticleMayo Clinic proceedings. Digital health2024

Echocardiographic Diagnosis of Hypertrophic Cardiomyopathy by Machine Learning.

Nasibeh Zanjirani Farahani, Mateo Alzate Aguirre, Vanessa Karlinski Vizentin, Moein Enayati, J Martijn Bos, Andredi Pumarejo Medina, Kathryn F Larson, Kalyan S Pasupathy, Christopher G Scott, April L Zacher and 10 more

Abstract read
In one paragraph

Article in Mayo Clinic proceedings. Digital health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Nasibeh Zanjirani FarahaniDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, MN.
Mateo Alzate AguirreDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, MN.
Vanessa Karlinski VizentinDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, MN.
Moein EnayatiDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, MN.
J Martijn BosDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, MN.
Andredi Pumarejo MedinaDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, MN.
Kathryn F LarsonDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, MN.
Kalyan S PasupathyDivision of Biomedical and Health Information Sciences, University of Illinois at Chicago, Chicago, IL.
Christopher G ScottDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, MN.
April L ZacherDepartment of Information Technology, Mayo Clinic, Rochester, MN.
Eduard SchlechtingerDepartment of Information Technology, Mayo Clinic, Rochester, MN.
Bruce K DanielsDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, MN.
Vinod C KaggalDepartment of Information Technology, Mayo Clinic, Rochester, MN.
Jeffrey B GeskeDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, MN.
Patricia A PellikkaDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, MN.
Jae K OhDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, MN.
Steve R OmmenDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, MN.
Garvan C KaneDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, MN.
Michael J AckermanDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, MN.
Adelaide M Arruda-OlsonDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, MN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To develop machine learning tools for automated hypertrophic cardiomyopathy (HCM) case recognition from echocardiographic metrics, aiming to identify HCM from standard echocardiographic data with high performance. Patients and Methods: Four different random forest machine learning models were developed using a case-control cohort composed of 5548 patients with HCM and 16,973 controls without HCM, from January 1, 2004, to March 15, 2019. Each patient with HCM was matched to 3 controls by sex, age, and year of echocardiography. Ten-fold crossvalidation was used to train the models to identify HCM. Variables included in the models were demographic characteristics (age, sex, and body surface area) and 16 standard echocardiographic metrics. Results: The models were differentiated by global, average, individual, or no strain measurements. Area under the receiver operating characteristic curves (area under the curve) ranged from 0.92 to 0.98 for the 4 separate models. Area under the curves of model 2 (using left ventricular global longitudinal strain; 0.97; 95% CI, 0.95-0.98), 3 (using averaged strain; 0.96; 95% CI, 0.94-0.97), and 4 (using 17 individual strains per patient; 0.98; 95% CI, 0.97-0.99) had comparable performance. By comparison, model 1 (no strain data; 0.92; 95% CI, 0.90-0.94) had an inferior area under the curve. Conclusion: Machine learning tools that analyze echocardiographic metrics identified HCM cases with high performance. Detection of HCM cases improved when strain data was combined with standard echocardiographic metrics.

Identifiers

PMID40206535
PMCPMC11975843

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.